Get started
Teladoc Health, Inc.Teladoc Health, Inc.Teladoc Health, Inc.

Teladoc Health, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

4LL chart


Full chart

4LL upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.10 B‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.947 CHF
Net income (FY)
‪−909.33 M‬ CHF
Revenue (FY)
‪2.33 B‬ CHF
Shares float
‪174.69 M‬
Beta (1Y)
1.50

Employees


Employees (FY)
‪5.5 K‬
Change (1Y)
−100 −1.79%
Revenue / Employee (1Y)
‪424.31 K‬ CHF
Net income / Employee (1Y)
‪−165.33 K‬ CHF

About Teladoc Health, Inc.


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Charles Divita
Website
teladochealth.com
Headquarters
New York
Founded
2002
ISIN
US87918A1051
FIGI
BBG00LVGGVB5
Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Check out other big names from the same industry as 4LL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

4LL news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

4LL highest yielding bonds


TDOC5196025
Teladoc Health, Inc. 1.25% 01-JUN-2027
Yield to maturity
—
Maturity date
Jun 1, 2027

See all 4LL bonds 

Frequently Asked Questions


The current price of 4LL is 6.205 CHF — it has increased by 0.98% in the past 24 hours. Watch Teladoc Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange Teladoc Health, Inc. stocks are traded under the ticker 4LL.
We've gathered analysts' opinions on Teladoc Health, Inc. future price: according to them, 4LL price has a max estimate of 9.69 CHF and a min estimate of 5.65 CHF. Watch 4LL chart and read a more detailed Teladoc Health, Inc. stock forecast: see what analysts think of Teladoc Health, Inc. and suggest that you do with its stocks.
4LL reached its all-time high on Oct 28, 2021 with the price of 135.532 CHF, and its all-time low was 5.532 CHF and was reached on May 23, 2025. View more price dynamics on 4LL chart.
See other stocks reaching their highest and lowest prices.
4LL stock is 0.97% volatile and has beta coefficient of 1.50. Track Teladoc Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Teladoc Health, Inc. there?
Today Teladoc Health, Inc. has the market capitalization of ‪1.11 B‬, it has decreased by −0.67% over the last week.
Yes, you can track Teladoc Health, Inc. financials in yearly and quarterly reports right on TradingView.
Teladoc Health, Inc. is going to release the next earnings report on Oct 22, 2025. Keep track of upcoming events with our Earnings Calendar.
4LL earnings for the last quarter are −0.15 CHF per share, whereas the estimation was −0.20 CHF resulting in a 26.34% surprise. The estimated earnings for the next quarter are −0.20 CHF per share. See more details about Teladoc Health, Inc. earnings.
Teladoc Health, Inc. revenue for the last quarter amounts to ‪501.35 M‬ CHF, despite the estimated figure of ‪493.92 M‬ CHF. In the next quarter, revenue is expected to reach ‪496.35 M‬ CHF.
4LL net income for the last quarter is ‪−25.91 M‬ CHF, while the quarter before that showed ‪−82.34 M‬ CHF of net income which accounts for 68.53% change. Track more Teladoc Health, Inc. financial stats to get the full picture.
No, 4LL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 19, 2025, the company has ‪5.5 K‬ employees. See our rating of the largest employees — is Teladoc Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Teladoc Health, Inc. EBITDA is ‪146.82 M‬ CHF, and current EBITDA margin is 6.77%. See more stats in Teladoc Health, Inc. financial statements.
Like other stocks, 4LL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Teladoc Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Teladoc Health, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Teladoc Health, Inc. stock shows the sell signal. See more of Teladoc Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.